KVUE:NYSEKenvue Inc. Analysis

Kenvue (KVUE) is trading at $17.26, below its 20‑day ($17.41), 50‑day ($17.94) and 200‑day ($18.20) moving averages, indicating a short‑term bearish price trend, while the RSI of 44.6 suggests neutral momentum. The MACD line sits just above the signal line, producing a modest bullish histogram (+0.017), and the stock finds support near $16.64 with resistance around $17.96, framing a tight trading range. Volatility is elevated at roughly 22.9% (30‑day) but beta is low (0.33), tempering market‑wide risk, and the dividend yield remains attractive at 4.78% despite a payout ratio exceeding 100%, raising sustainability concerns.
Fundamentally, KVUE posted modest revenue growth of 3.2% YoY, with solid gross (58.4%) and operating (17.8%) margins, and generated $1.81 B in free cash flow, yet it carries a high debt load (Debt‑to‑Equity ~80%). The DCF‑derived fair value of $10.64 suggests the market is pricing in a premium, though analyst consensus targets of $19.5‑$19.75 imply a potential upside of around 14%. Recent earnings beat and strength in the beauty segment have buoyed sentiment, but the unsustainable dividend and leverage temper enthusiasm, leading to a balanced outlook.